Subretinal Fibrosis Identified and Confirmed as Collagen for the First Time

Subretinal fibrosis, often identified as Subretinal Hyperreflective Material (SHRM) on OCT, has long been difficult to characterize. While SHRM includes various extracellular matrix components, Collagen Hybridizing Peptides (CHPs) have now confirmed collagen remodeling as a major contributor for the first time. This breakthrough enables precise detection and monitoring of remodeling collagen, providing new insights into subretinal fibrosis and advancing nAMD research.

How CHPs Address Key Challenges in nAMD Research

CHPs empower researchers to precisely detect, monitor, and study fibrosis dynamics, transforming our understanding of subretinal fibrosis in nAMD.

Pinpointing Collagen Remodeling

CHPs enable precise detection of remodeling collagen, helping researchers identify fibrotic regions within SHRM with unmatched accuracy.

Unveiling Fibrosis Dynamics

CHPs facilitate real-time tracking of fibrosis progression, regression, or stabilization, offering valuable insights into disease evolution.

Quantifying Treatment Impact

CHPs provide a reliable metric to measure therapeutic efficacy, enabling precise evaluation of anti-fibrotic treatments in nAMD.

Facilitating Biomarker Discovery

CHPs support the identification of fibrosis-related biomarkers, paving the way for targeted therapies and personalized treatment strategies.